ABUS vs KHC · P/E 5.4, rev $6.2M vs P/E 12, $31.55B cap
Arbutus Biopharma Corp (ABUS) versus Kraft Heinz Co (KHC) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Kraft Heinz Co (KHC) is a packaged foods company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
KHC does not have a complete income-statement cache yet.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. KHC currently screens at market cap $31.55B and trailing P/E 12.2.
Not investment advice. Open the ABUS and KHC stock pages for the full models.
Not investment advice.